Cognito Therapeutics is a leader in non-invasive neuromodulation aimed at treating neurodegenerative diseases and enhancing cognitive performance. The company has conducted multiple clinical studies showing promise in slowing or stopping cognitive decline and brain volume loss in Alzheimer's disease, with FDA Breakthrough Device Designation. Founded on groundbreaking optogenetics research by MIT professors, Cognito is poised to begin pivotal trials in 2022.
Cognito Therapeutics is seeking a Quality Engineer to drive quality engineering methodologies, systems, and practices within their medical device company. The role involves ensuring compliance with regulations, supporting product documentation, and contributing to continuous improvement. They are a fast-growing company dedicated to translating scientific findings into therapeutic approaches for neurodegenerative conditions.
Cognito Therapeutics is a leader in non-invasive neuromodulation aimed at treating neurodegenerative diseases and enhancing cognitive performance. The company has conducted multiple clinical studies showing promise in slowing or stopping cognitive decline and brain volume loss in Alzheimer's disease, with FDA Breakthrough Device Designation. Founded on groundbreaking optogenetics research by MIT professors, Cognito is poised to begin pivotal trials in 2022.